China Biotech Services Holdings Limited (HKG:8037)

HKG:8037 Revenue

In the year 2025, China Biotech Services Holdings had annual revenue of 73.50M HKD with 4.25% growth. China Biotech Services Holdings had revenue of 34.63M in the half year ending December 31, 2025, with 16.89% growth.

• Revenue: 73.50M
• Revenue Growth: +4.25%
• P/S Ratio: 9.16
• Revenue / Employee: 544.47K
• Employees: 135
• Market Cap: 673.25M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.50M	2.99M	4.25%
Dec 31, 2024	70.51M	-141.48M	-66.74%
Dec 31, 2023	211.99M	-1.64B	-88.55%
Dec 31, 2022	1.85B	1.23B	196.83%
Dec 31, 2021	623.76M	-32.03M	-4.88%